International Biotechnology Trust plc (IBT) - Total Assets
Based on the latest financial reports, International Biotechnology Trust plc (IBT) holds total assets worth GBX284.04 Million GBX (≈ $34.56K USD) as of August 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check International Biotechnology Trust plc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
International Biotechnology Trust plc - Total Assets Trend (2000–2025)
This chart illustrates how International Biotechnology Trust plc's total assets have evolved over time, based on quarterly financial data. Explore IBT long-term investment intensity to see how much of total assets are deployed in long-term investments.
International Biotechnology Trust plc - Asset Composition Analysis
Current Asset Composition (August 2025)
International Biotechnology Trust plc's total assets of GBX284.04 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 5.3% |
| Accounts Receivable | GBX66.00K | 0.0% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how International Biotechnology Trust plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see IBT stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: International Biotechnology Trust plc's current assets represent 0.0% of total assets in 2025, unchanged from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 0.0% of total assets.
International Biotechnology Trust plc Competitors by Total Assets
Key competitors of International Biotechnology Trust plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $8.68 Billion |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.98 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
China | CN¥6.82 Billion |
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
|
China | CN¥3.25 Billion |
International Biotechnology Trust plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.46 | 4.04 |
| Quick Ratio | 0.12 | 0.46 | 4.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX-36.46 Million | GBX-18.56 Million | GBX9.68 Million |
International Biotechnology Trust plc - Advanced Valuation Insights
This section examines the relationship between International Biotechnology Trust plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.26 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -7.8% |
| Total Assets | GBX284.04 Million |
| Market Capitalization | $3.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values International Biotechnology Trust plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: International Biotechnology Trust plc's assets decreased by 7.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for International Biotechnology Trust plc (2000–2025)
The table below shows the annual total assets of International Biotechnology Trust plc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-08-31 | GBX284.04 Million ≈ $34.56K |
-7.83% |
| 2024-08-31 | GBX308.15 Million ≈ $37.49K |
+1.08% |
| 2023-08-31 | GBX304.87 Million ≈ $37.09K |
-6.74% |
| 2022-08-31 | GBX326.92 Million ≈ $39.78K |
-6.01% |
| 2021-08-31 | GBX347.83 Million ≈ $42.32K |
+14.91% |
| 2020-08-31 | GBX302.71 Million ≈ $36.83K |
+25.68% |
| 2019-08-31 | GBX240.86 Million ≈ $29.31K |
-8.49% |
| 2018-08-31 | GBX263.22 Million ≈ $32.03K |
-3.35% |
| 2017-08-31 | GBX272.34 Million ≈ $33.14K |
+17.83% |
| 2016-08-31 | GBX231.12 Million ≈ $28.12K |
-11.68% |
| 2015-08-31 | GBX261.68 Million ≈ $31.84K |
+15.99% |
| 2014-08-31 | GBX225.61 Million ≈ $27.45K |
+30.49% |
| 2013-08-31 | GBX172.90 Million ≈ $21.04K |
+33.90% |
| 2012-08-31 | GBX129.12 Million ≈ $15.71K |
+27.44% |
| 2011-08-31 | GBX101.32 Million ≈ $12.33K |
+6.57% |
| 2010-08-31 | GBX95.07 Million ≈ $11.57K |
-3.70% |
| 2009-08-31 | GBX98.72 Million ≈ $12.01K |
-13.92% |
| 2008-08-31 | GBX114.69 Million ≈ $13.95K |
+10.16% |
| 2007-08-31 | GBX104.11 Million ≈ $12.67K |
+55.11% |
| 2006-08-31 | GBX67.12 Million ≈ $8.17K |
+14.27% |
| 2005-08-31 | GBX58.73 Million ≈ $7.15K |
+5.77% |
| 2004-08-31 | GBX55.53 Million ≈ $6.76K |
+2.19% |
| 2003-08-31 | GBX54.34 Million ≈ $6.61K |
+11.96% |
| 2002-08-31 | GBX48.54 Million ≈ $5.91K |
-51.74% |
| 2001-08-31 | GBX100.58 Million ≈ $12.24K |
-72.53% |
| 2000-08-31 | GBX366.17 Million ≈ $44.55K |
-- |
About International Biotechnology Trust plc
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies fo… Read more